Skip to main content
OpenTrials
Completed

NCT Number: NCT05118035

Applying an Artificial Intelligence-Enabled Electrocardiographic System for Reducing Mortality

This is a randomized controlled trial (RCT) to test a novel artificial intelligence (AI)-enabled electrocardiogram (ECG)-based screening tool for early detection of clinical deterioration for reducing mortality.

Completed

Looking for future studies?

Notify Me

Key information

Conditions

Cardiovascular Diseases Intensity Care Morality

Age range

18 year and older

Sex eligibility

All sexes

Study type

Interventional

Phase

Not applicable

Primary location

National Defense Medical Center

Taipei, 114, Taiwan

Who can participate

Healthy volunteers accepted: No

Only the study team can determine whether someone qualifies for participation.

Inclusion criteria

  • Patients in emergency department or inpatient department.
  • Patients recieved at least 1 ECG examination.

Exclusion criteria

  • The patients recieved ECG at the period of inactive AI-ECG system.

Treatment and study plan

AI-enabled ECG-based Screening Tool

Other

Primary care clinicians in the intervention group had access to the report, which shows the risk prediction results for each patients. Moreover, the clinicians will recieve a short message when patients with a high risk ECG identified by AI.

Primary outcomes

  1. All cause mortality (death)

    Time frame: Within 90 days

    After performing an electrocardiogram, the patient's survival is tracked.

Secondary outcomes

  1. Cardiovascular cause mortality (death)

    Time frame: Within 90 days

    After performing an electrocardiogram, the patient's survival is tracked.

  2. Arrhythmia medication

    Time frame: Within 12 hours

    After performing an electrocardiogram, the patient recieved related intervention.

  3. Electrolyte examination

    Time frame: Within 3 days

    After performing an electrocardiogram, the patient recieved electrolyte examination

  4. Cadiac examination

    Time frame: Within 3-7 days

    After performing an electrocardiogram, the patient recieved cadiac examination

Sponsors and collaborators

Lead sponsor

National Defense Medical Center, Taiwan

Other

Registry information

Official study title

Applying an Artificial Intelligence-Enabled Electrocardiographic System for Reducing Mortality: a Pragmatic Randomized Clinical Trial

Important dates

Study start
2021
Primary completion
2022
Study completion
2022
First posted
Nov 11, 2021
Registry last updated
Feb 8, 2023

OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.

View the official ClinicalTrials.gov record (opens in a new tab)

This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.

Related clinical trials

Published trials that share one or more normalized conditions with this study.